Fell-Muir lecture: Connective tissue growth factor (CCN2) - a pernicious and pleiotropic player in the development of kidney fibrosis

International Journal of Experimental Pathology

Volumn 94, Issue 1, 2013, Pages 1-16

  Mason, Roger M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

CCN2; Chronic kidney disease; Connective tissue growth factor; Connective tissue growth factor receptors; Fibrosis; TGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CONNECTIVE TISSUE GROWTH FACTOR; HEPARAN SULFATE; INTEGRIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MICRORNA; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; ONCOSTATIN M; OSTEOGENIC PROTEIN 1; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TROPOMYOSIN; TROPOMYOSIN RELATED KINASE A; UNCLASSIFIED DRUG;

CELL CYCLE ARREST; CELL SURVIVAL; DOWNSTREAM PROCESSING; EXTRACELLULAR MATRIX; HUMAN; KIDNEY CELL; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; MESANGIUM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINES; DISEASE PROGRESSION; FIBROSIS; HUMANS; INFLAMMATION MEDIATORS; KIDNEY; KIDNEY DISEASES; PROGNOSIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84872500380     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2012.00845.x     Document Type: Review

References (120)

1. Abreu J.G., Ketpura N.I., Reversade B., de Robertis E.M. (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGFβ. Nat. Cell Biol. 4, 599-604.
2. Adler S.G., Schwartz S., Williams M.E. et al. (2010) Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria. Clin. J. Am. Soc. Nephrol. 5, 1420-1428.
3. Allen S.J. & Dawbarn D. (2006) Clinical relevance of the neurotrophins and their receptors. Clin. Sci. 110, 175-191.
4. Bonofiglio R., Antonucci M.T., Papalia T. et al. (2007) Nerve growth factor (NGF) and NGF-receptor expression in diseased human kidneys. J. Nephrol. 20, 186-195.
5. Boutet A., de Frutos C.A., Maxwell P.H., Mayol M.J., Romero J., Nieto M.A. (2006) Snail1 activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J. 25, 5603-5613.
6. Bradham D.M., Igarashi A., Potter R.L., Grotendorst G.R. (1991) Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J. Cell Biol. 114, 1285-1294.
7. Campbell I.D. & Humphries M.J. (2011) Integrin structure, activation and interactions. Cold Spring Harb. Perspect. Biol. 3, a004994.
8. Chao M.V., Rajagopal R., Lee F.S. (2006) Neurotrophin signalling in health and disease. Clin. Sci. 110, 167-173.
9. Chen C.-C. & Lau L.F. (2009) Functions and mechanisms of action of CCN matricellular proteins. Int. J. Biochem. Cell Biol. 41, 771-783.
10. Chen S.J., Yuan W., Lo S., Trojanowska M., Varga J. (2000) Interaction of smad3 with a proximal smad-binding element of the human alpha2 (I) procollagen gene promoter required for transcriptional activation by TGF-beta. J. Cell. Physiol. 183, 381-392.
11. Chujo S., Shirasaki F., Kawara S. et al. (2005) Connective tissue growth factor causes persistent proa2 (I) collagen gene expression induced by transforming growth factor-b in a mouse fibrosis model. J. Cell Physiol. 203, 447-456.
12. Cicha I., Yilmaz A., Klien M. et al. (2005) Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Artioscler. Thromb. Vasc. Biol. 25, 1008-1013.
13. Crean J.K.G., Findlay D., Murphy M. et al. (2002) The Role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix production, cell migration and actin cytoskeletal rearrangement in human mesangial cells. J. Biol. Chem 46, 44187-44194.
14. Crean J.K., Furlong F., Finlay D. et al. (2004) Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization. FASEB J. 20, 1712-1724.
15. Cunningham M.E., Stephens R.M., Kaplan D.R., Greene L.A. (1997) Autophosphorylation of activation loop tyrosines regulates signalling by the TRK nerve growth factor receptor. J. Biol. Chem. 272, 10957-10967.
16. De Winter P., Leoni P., Abraham D. (2009) Connective tissue growth factor; Structure-function relationships of a mosaic, multifunctional protein. Growth Factors 26, 80-91.
17. Dean R.A., Butler G.S., Hamma-Kourbali Y. et al. (2007) Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotropin) and VEGF/connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Mol. Cell Biol. 27, 8454-8465.
18. Dendooven A., Nguyen T.Q., Rosens L. et al. (2011) The CTGF-945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetes. J. Negat. Results Biomed. 10, 4.
19. Duisters R.F., Tijsen A.J., Schroen B. et al. (2009) MiR-133 and miR-30 regulate connective tissue growth factor. Implications for a role of microRNAs in myocardial matrix remodelling. Circ. Res. 104, 170-178.
20. Edwards L.A., Woolard K., Son M.J. et al. (2011) Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J. Natl Cancer Inst. 103, 1-17.
21. Flanders K.C. (2004) Smad3 as a mediator of the fibrotic response. Int. J. Exp. Pathol. 85, 47-64.
22. Floege J. & Johnson R.J. (1993) Cytokines in renal inflammation. Curr. Opin. Nephrol. Hypertens. 2, 449-457.
23. Fonseca C., Lindahl G.E., Ponticos M. et al. (2007) A polymorphism in the CTGF promoter region associated with systemic sclerosis. N. Engl. J. Med. 357, 1210-1220.
24. Fragiadaki M. & Mason R.M. (2011) Epithelial-mesenchymal transition in renal fibrosis - evidence for and against. Int. J. Exp. Pathol. 92, 143-150.
25. Fragiadaki M., Witherden A.S., Kaneko T. et al. (2011) Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells in vivo. Matrix Biol. 30, 396-403.
26. Fragiadaki M., Hill N., Hewitt R. et al. (2012) Hyperglycaemia causes renal cell damage via CCN2-induced activation of the TrkA receptor: implications for diabetic nephropathy. Diabetes 61, 2280-2288.
27. Frazier K.S., Paredes A., Dube P., Styer E. (2000) Connective tissue growth factor expression in the rat remnant kidney model and association with tubular epithelial cells undergoing transdifferentiation. Vet. Pathol. 37, 328-335.
28. Gao R. & Brigstock D.R. (2003) Low density lipoprotein receptor-related protein (LRP) is a heparin dependant receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol. Res. 27, 214-220.
29. Gao R. & Brigstock D.R. (2004) Connective tissue growth factor (CCN2) induces adhesion of rat hepatic stellate cells by binding of its C-terminal domain to integrin alpha (v) beta (3) and heparin sulphate proteoglycan. J. Biol. Chem. 279, 8848-8855.
30. Gao R. & Brigstock D.R. (2005) Connective tissue growth factor (CCN2) in rat pancreatic stellate cell function: integrin α5β1 as a novel CCN2 receptor. Gastroenterology, 120, 1019-1030.
31. Gonias S.L., Wu L., Salicioni A.M. (2004) Low density lipoprotein receptor-related protein: regulation of the plasma membrane proteome. Thromb. Haemost. 91, 1056-1064.
32. Grimes M.L., Zhou J., Beattie E.C. et al. (1996) Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signalling endosomes. J. Neurosci. 16, 7950-7964.
33. Guha M., Xu Z.-G., Tung D., Lanting L., Natarajan R. (2007) Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J. 21, 3355-3368.
34. Higgins D.F., Biju M.P., Akai Y., Wutz A., Johnson R.S., Haase V.H. (2004) Hypoxic induction of Ctgf is directly mediated by Hif-1. Am. J. Renal Physiol. 287, F1223-F1232.
35. Hishikawa K., Oemar B.S., Nakaki T. (2001) Static pressure regulates connective tissue growth factor expression in human mesangial cells. J. Biol. Chem. 276, 16797-16803.
36. Hu K., Wu C., Mars W.M., Liu Y. (2007) Tissue-type plasminogenactivator promotes murine myofibroblast activation through LDL receptor-related protein-1-mediated integrin signalling. J. Clin. Invest. 117, 3821-3832.
37. Humphreys B.D., Lin S.L., Kobayashi A. et al. (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85-97.
38. Igarashi A., Okochi H., Bradham D.M., Grotendorst G.R. (1993) Regulation of connective tissue growth factor expression in human skin fibroblasts and during wound repair. Mol. Biol. Cell 4, 637-645.
39. Igarashi A., Nashiro K., Kikuchi K., Sato S. et al. (1995) Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J. Invest. Dermatol. 105, 280-284.
40. Inoue T., Okada H., Kobayashi T. et al. (2003) Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J. 17, 268-270.
41. Ito Y., Aten J., Bende R.J. et al. (1998) Expression of Connective tissue growth factor in human renal fibrosis. Kidney Int. 53, 853-861.
42. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110, 341-350.
43. Johnsen S.A., Subramaniam M., Janknecht R., Spelsberg T.C. (2002) TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses. Oncogene 21, 5783-5790.
44. Jun J.I. & Lau L.F. (2011) Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat. Rev. Drug Discov. 10, 945-963.
45. Kanemoto K., Usui J., Nitta K., Horita S., Koyama A. et al. (2004) In situ expression of connective tissue growth factor in human crescentric glomerulonephritis. Virchows Arch. 444, 257-263.
46. Klahr S. & Morrissey J. (2002) Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 283, F861-F875.
47. Leask A., Parapuram S.K., Shi-wen X. & Abraham D.J. (2009) Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? J. Cell Commun. Signal. 3, 89-94.
48. Lin S.-L., Kisseleva T., Brenner D.A., Duffield J.S. (2008) Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617-1727.
49. Liu Y. (2011) Cellular and molecular mechanisms of renal fibrosis. Nat. Rev. Nephrol. 7, 684-696.
50. Liu S., Taghavi R., Leask A. (2010) Connective tissue growth factor is induced in bleomycin-induced skin scleroderma. J. Cell Commun. Signal. 4, 25-30.
51. Liu S., Shi-wen X., Abraham D.J., Leask A. (2011) CCN2 is required for bleomycin-induced skin fibrosis in mice. Arth. Rheum. 63, 239-246.
52. Lόpez-Hernandez F.J., Lόpez-Nova J.M. (2012) Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res. 347, 141-154.
53. Mason R.M. (2009) Connective tissue growth factor (CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it? J. Cell Commun. Signal. 3, 95-104.
54. Mason R.M., Li X.J., Wahab N.A. (1997) High glucose induces the expression of connective tissue growth factor in human mesangial cells. J. Am. Soc. Nephrol. 8, 642A.
55. McDonald P.C., Fielding A.B., Dehar S. (2011) Integrin-linked kinase - essential roles in physiology and cancer biology. J. Cell Sci. 121, 3121-3132.
56. Mercurio S., Latinkic B., Itasaki N., Krumlauf R., Smith J.C. (2004) Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131, 2137-2147.
57. Mezzano S.A., Barria M., Droguett M.A. et al. (2001) Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int. 60, 1366-1377.
58. Mezzano S., Aros C., Droguett A. et al. (2004) NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol. Dial. Transplant. 19, 2505-2512.
59. Miaczynska M., Pelkmans L., Zerial M. (2004) Not just a sink: endosomes in control of signal transduction. Curr. Opin. Cell Biol. 16, 400-406.
60. Millard M., Odde S., Neamati N. (2011) Integrin targeted therapeutics. Theranostics 1, 154-188.
61. Miyazawa K., Hara T., Furuya T., Miyazono K. (2002) Two major smad pathways in TGF-β superfamily signalling. Genes Cells 7, 1191-1204.
62. Mori T., Kawara S., Shinozaki M. et al. (1999) Role and interaction of connective tissue growth factor with transforming growth factor beta in persistent fibrosis: a mouse fibrosis model. J. Cell Physiol. 181, 153-159.
63. Mori Y., Hinchcliff M., Wu M., Warner-Blankenship M., Lyons K., Varga J. (2008) Connective tissue growth factor. CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-β responsiveness. Exp. Cell Res. 314, 1094-1104.
64. Murphy M., Godson C., Cannon S. et al. (1999) Supression subtractive hybridization identifies high glucose level as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J. Biol. Chem. 274, 5830-5834.
65. Nakerakanti S.S., Bujor A.M., Trojanowska M. (2011) CCN2 is required for the TGF-β induced activation of smad1-Erk 1/2 signalling network. PLoS ONE 6, e21911.
66. Nelson P.J., von Toerne C., Grone H.J. (2011) Wnt-signaling pathways in progressive renal fibrosis. Expert Opin. Ther. Targets. 15, 1073-1083.
67. Nguyen T.Q., Roestenberg P., van Nieuwenhoven F.A. et al. (2008) CTGF inhibits BMP-7 signaling in diabetic nephropathy. J. Am. Soc. Nephrol. 19, 2098-2107.
68. Nightingale J., Patel S., Suzuki N. et al. (2004) Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. J. Am. Soc. Nephrol. 15, 21-32.
69. Nishida T., Nakanishi T., Shimo T. et al. (1998) Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). Biochem. Biophys. Res. Commun. 247, 905-909.
70. Nonaka T.S., Fujita T., Takahashi T. et al. (2008) TGF-beta1 and CTGF mRNAs are correlated with urinary protein level in IgA nephropathy. J. Nephrol. 21, 53-63.
71. O'Donovan H.C., Hickey F., Brazil D.P. et al. (2012) Connective tissue growth factor antagonizes transforming growth factor-β/Snad signalling in renal mesangial cells. Biochem. J. 441, 499-510.
72. Okada H., Inoue T., Kanno Y. et al. (2002) Interstitial fibroblast-like cells express renin-angiotensin system components in a fibrosing murine kidney. Am. J. Pathol. 160, 765-772.
73. Okada H., Kikuta T., Kobayashi T. et al. (2005) Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J. Am. Soc. Nephrol. 16, 133-143.
74. Panek A.N., Posch M.G., Alenina N. et al. (2009) Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertropy and protection against pressure overload. PLoS One. e6743.
75. Pannu J., Asano Y., Nakerakanti S. et al. (2008) Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate. Arthritis Rheum. 58, 2528-2537.
76. Patel V. & Noureddine L. (2012) MicroRNAs and Fibrosis. Curr. Opin. Nephrol. Hypertens. 21, 410-416.
77. Perbal B. (2009) Alternative splicing of CCN mRNAs...it has been upon us. J. Cell. Commun. Signal. 3, 153-157.
78. Pi L., Xia H., Liu J., Shenoy A.K., Hauswirth W.W., Scott E.W. (2011) Role of connective tissue growth factor in retinal vasculature during development. Invest. Ophthalmol. Vis. Sci. 52, 8701-8710.
79. Pollack V., Sarkozi R., Banki Z. et al. (2007) Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signalling. Am. J. Physiol. Renal Physiol. 293, F1714-F1726.
80. Ren S., Babelova A., Moreth K. et al. (2009) Transforming growth factor-beta2 upregulates sphingosine kinase-1activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression. Kidney Int. 76, 857-867.
81. Riser B.L., Denichilo M., Cortes P. et al. (2000) regulation of connective tissue growth factor activity in cultured rat mesangial cells and in experimental diabetic glomerulosclerosis. J. Am. Soc. Nephrol. 11, 25-38.
82. Riser B.L., Najmabadi F., Perbal B. et al. (2009) CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am. J. Pathol. 174, 1725-1734.
83. Rodriguez-Pena A.B., Grande M.T., Eleno N. et al. (2008) Activation of Erk1/2 and Akt following unilateral ureteral obstruction. Kidney Int. 74, 196-209.
84. Rooney B., O'Donovan H., Gaffney A. et al. (2011) CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: implications for the pathogenesis of diabetic nephropathy. FEBS Lett. 585, 531-538.
85. Rueda B., Simeon C., Hesselstrand R. et al. (2009) A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Ann. Rheum. Dis. 68, 1618-1620.
86. Ryseck R.P., Macdonald-Bravo H., Mattéi M.G., Bravo R. (1991) Structure, mapping and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ. 2, 225-233.
87. Sanchez-Lopez E., Rayego S., Rodrigues-Diez R. et al. (2009) CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-κB. J. Am. Soc. Nephrol. 20, 1513-1526.
88. Sarkozi R., Hauser C., Noppert S.J. et al. (2011) Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression. Am. J. Physiol. Renal Physiol. 301, F1014-F1025.
89. Schecterson L.C. & Bothwell M. (2010) Neurotrophin receptors: old friends with new partners. Dev. Neurobiol. 70, 332-338.
90. Schober J.M., Chen N., Grzeskiewicz T.M. et al. (2002) Identification of integrin αMβ2 as an adhesion receptor on peripheral blood monocytes for cyr 61 (CCN1) and connective tissue growth factor CTGF): immediate early gene products expressed in atherosclerosis. Blood 99, 4457-4465.
91. Schrimpf C. & Duffield J.S (2011) Mechanisms of fibrosis: the role of the pericyte. Curr. Opin. Nephrol. Hypertens 20, 297-305.
92. Segarini P.R., Nesbitt J.E., Li D., Hays L.G., Yates III J.R., Carmichael D.F. (2001) The low density lipoprotein receptor-related protein/macroglobulin receptor is a receptor for connective tissue growth factor. J. Biol. Chem. 44, 40659-40667.
93. Shi S., Yu L., Chiu C. et al. (2008) Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J. Am. Soc. Nephrol. 19, 2159-2169.
94. Shi-Wen X., Leask A., Abraham D. (2008) Regulation and function of connective tissue growth factor in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 19, 133-144.
95. Sonnylai S., Shi-wen X., Leoni P. et al. (2010) Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic fibrosis. Arthritis Rheum. 62, 1523-1532.
96. Stanisavljevic J., Porta-de-la Riva M., Batile R., de Herreros A.G., Baulida J. (2011) The p65 subunit of NF-κB and PARP1 assist Snail1 in activating fibronectin transcription. J. Cell Sci. 124, 4161-4171.
97. Suzuki D., Toyoda M., Umezono T., Uehara G., Zhang S.Y. et al. (2003) Glomerular expression of connective tissue growth factor mRNA in various renal diseases. Nephrology (Carlton) 8, 92-97.
98. Sysa P., Potter J.J., Liu X., Mezey E. (2009) Transforming growth factor-b1 up-regulation of human a1 (I) collagen is mediated by Sp1 and smad2 transacting factors. DNA Cell Biol. 28, 425-434.
99. Thomson S.E., McLennan S.V., Kirwan P.D. et al. (2008) Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. J. Diabetes Complicat. 22, 284-294.
100. Tominaga T., Abe H., Ueda O. et al. (2011) Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy. J. Biol. Chem. 286, 20109-20116.
101. Trojanowska M. (2009) Noncanonical transforming growth factor β signalling in scleroderma fibrosis. Curr. Opin. Rheumatol. 21, 623-629.
102. Wahab N.A. & Mason R.M. (2006) A critical look at growth factors and epithelial to mesenchymal transition in the adult kidney. Nephron Exp. Nephrol. 104, 129-134.
103. Wahab N.A., Yevdokimova N., Weston B.S. et al. (2001a) Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem. J. 359, 77-87.
104. Wahab N.A., Brinkman H., Mason R.M. (2001b) Uptake and intracellular transport of the connective tissue growth factor: a potential mode of action. Biochem. J. 359, 89-97.
105. Wahab N.A., Weston B.S., Roberts T., Mason R.M. (2002) Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. J. Am. Soc. Nephrol. 13, 2437-2445.
106. Wahab N.A., Schaefer L., Weston B.S. et al. (2005a) Glomerular expression of thrombospondin -1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial responses to diabetic stimuli. Diabetologia 48, 2650-2660.
107. Wahab N.A., Weston B.S., Mason R.M. (2005b) Modulation of the TGFβ/Smad signalling pathway in mesangial cells by CTGF/CCN2. Exp. Cell Res. 307, 305-315.
108. Wahab N.A., Weston B.S., Mason R.M. (2005c) Connective tissue growth factor CCN2 interacts with and activates the tryrosine kinase receptor TrkA. J. Am. Soc. Nephrol. 16, 340-351.
109. Wahab N., Cox D., Witherden A., Mason R.M. (2007) Connective tissue growth factor (CTGF)promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phphatase-1 (MKP-1). Biochem. J. 406, 131-138.
110. Wang S. & Hirschberg R. (2003) BMP7 antagonizes TGF-β- dependent fibrogenesis in mesangial cells. Am. J. Physiol. Renal Physiol. 284, 1006-1013.
111. Wang S., Denichilo M., Brubaker C., Hirschberg R. (2001a) Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int. 60, 96-105.
112. Wang S.N., Lapage J., Hirschberg R. (2001b) Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J. Am. Soc. Nephrol. 12, 2392-2399.
113. Wang Q., Usinger W., Nichols B. et al. (2011) Cooperative interaction of CTGF and TGFβ in animal models of fibrotic disease. Fibrogenesis Tissue Repair 4, 4-11.
114. Weston B.S., Wahab N.A., Mason R.M. (2003) CTGF mediates TGFβ induced fibronectin matrix deposition by upregulating active α5β1 integrin in human mesangial cells. J. Am. Soc. Nephrol. 14, 601-610.
115. Wolf G. & Ziyadeh F.N. (1999) Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 56, 393-405.
116. Wu S.H., Lu C., Dong L., Chen Z.Q. (2008) Signal transduction involved in CTGF-induced production of chemokines in mesangial cells. Growth Factors 26, 192-200.
117. Wynn T.A. (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 117, 524-529.
118. Yang M., Huang H., Li J., Li D., Wang H. (2004) Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation. FASEB J. 18, 1920-1931.
119. Yokoi H., Mukoyama M., Nagae T. et al. (2004) Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 15, 1430-1440.
120. Yokoi H., Mukoyama M., Mori K. et al. (2008) Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int. 73, 446-455.